Search

Your search keyword '"Baraldi, Anna"' showing total 240 results

Search Constraints

Start Over You searched for: Author "Baraldi, Anna" Remove constraint Author: "Baraldi, Anna"
240 results on '"Baraldi, Anna"'

Search Results

10. Early mortality in myeloma patients treated with first-generation novel agents thalidomide, lenalidomide, bortezomib at diagnosis: A pooled analysis

11. Does corruption hinder female political participation? Evidence from a measure against organized crime.

12. Eppur si muove: an evaluation of museum policy reform in Italy

14. Neutralizing the Tentacles of Organized Crime. Assessment of the Impact of an Anti-Crime Measure on Mafia Violence in Italy

18. Neutralizing the Tentacles of Organized Crime. Assessment of an Anti-Crime Measure in Fighting Mafia Violence

19. Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma

22. Hairy cell leukemias with unmutated IGHV genes define the minor subset refractory to single-agent cladribine and with more aggressive behavior

25. Do Voters Choose Better Politicians than Political Parties? Evidence from a Natural Experiment in Italy

26. Ixazomib-Based Induction Followed By Single-Agent Ixazomib Maintenance in Transplant Ineligible, Newly Diagnosed Multiple Myeloma Patients: Updated Results of the EMN10-Unito Trial

29. Efficacy and Safety of Ixazomib-Dexamethasone, Ixazomib-Cyclophosphamide-Dexamethasone, Ixazomib-Thalidomide-Dexamethasone and Ixazomib-Bendamustine-Dexamethasone for Elderly Newly Diagnosed Multiple Myeloma (NDMM) Patients: Analysis of the Phase II Randomized Unito-EMN10 Study

30. Public investment and growth accelerations: The case of Southern Italy, 1951-1995

32. Carfilzomib-Lenalidomide-Dexamethasone (KRd) Induction-Autologous Transplant (ASCT)-Krd Consolidation Vs KRd 12 Cycles Vs Carfilzomib-Cyclophosphamide-Dexamethasone (KCd) Induction-ASCT-KCd Consolidation: Analysis of the Randomized Forte Trial in Newly Diagnosed Multiple Myeloma (NDMM)

33. Clinical and Molecular Results of the Phase II Brb (Bendamustine, Rituximab and Bortezomib) Trial of the Fondazione Italiana Linfomi (FIL) for Relapsed/Refractory Waldenström Macroglobulinemia Patients

34. Efficacy and Feasibility of Dose/Schedule-Adjusted Rd-R Vs. Continuous Rd in Elderly and Intermediate-Fit Newly Diagnosed Multiple Myeloma (NDMM) Patients: RV-MM-PI-0752 Phase III Randomized Study

35. Democracy, Political Competition and Economic Growth

36. The Effect of the Proportionality Degree of Electoral Systems on Corruption

38. Electoral rules and Corruption: The role of Political Competition

39. Electoral Systems and Economic Growth: What is the Importance of the Proportionality Degree?

41. Impact of Treatment Intensification According to Patient Prognosis: A Pooled Analysis of 3 Randomized Phase III Trials

43. Osteonecrosis of the Jaws (ONJ) after Bisphosphonate Treatment in Patients with Multiple Myeloma: Decreasing ONJ Incidence after Adoption of Preventive Measures

45. SISTEMI ELETTORALI E CORRUZIONE: IL RUOLO DELLA CONCORRENZA POLITICA

46. The Transition Rate from High School to University: The Case of Italy

47. Il Tasso di Passaggio all’Università: un Confronto tra Centro-Nord e Mezzogiorno Italiano

48. Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy following autologous hematopoietic stem-cell transplantation in patients with newly diagnosed multiple myeloma

49. The Impact of Mixed Electoral Representation on Economic Growth: The case of the Italian Regions

50. Pass-through with Network Expernalities

Catalog

Books, media, physical & digital resources